AMBU RECEIVES CE MARK FOR FULL SURESIGHT VIDEO LARYNGOSCOPE PORTFOLIO IN EUROPE
20.4.2026 08:07:21 CEST | Ambu A/S | Press release
The SureSightTM portfolio strengthens Ambu’s Respiratory platform in Europe by offering clinicians and hospitals a fully integrated video laryngoscopy portfolio for difficult airway intubations.

Copenhagen, Denmark, 20 April 2026 – Ambu, the global market leader in single-use endoscopy, today announces receipt of a CE Mark and the upcoming gradual rollout of its entire SureSight video laryngoscope portfolio in Europe.
First launched in the USA and the UK in 2025, and now in the rest of Europe, the SureSight portfolio is designed to provide a clear airway view and support intubation in multiple healthcare settings, including the operating room (OR), intensive care unit (ICU), and emergency medical services (EMS). Video laryngoscopy combines advanced visualization of the glottis with ease of use, helping clinicians see the airway more clearly and achieve higher first-pass intubation success rates.1
While video laryngoscopy accounts for roughly 50% of all procedures in the U.S., it accounts for approximately one in 10 procedures in Europe, where it is primarily used for difficult airway intubations. However, its adoption as a standard intubation tool is increasing.
“The development of video laryngoscopy represented a significant advancement within airway management and has since become a gold standard practice. With the new SureSight portfolio, Ambu has integrated the option of video laryngoscopy into their existing respiratory platform, which is now capable of facilitating simultaneous usage with the aScope Broncho or VivaSight 2 devices to support a combined intubation technique across a single screen. The addition of the SureSight Mobile also ensures universal access to a video laryngoscope across a wide range of clinical settings for unexpected and unplanned procedures,” says Dr George Christodoulides, Consultant Anaesthetist, Guy’s and St Thomas’ NHS Foundation Trust, London, UK2.
The Ambu SureSight portfolio includes two complementary solutions: SureSight Connect and SureSight Mobile, both compatible with 10 single-use SureSight blades. SureSight Connect offers dual-view intubation with video laryngoscopy and the use of a single-use bronchoscope on one screen – ideal for teamwork and training while streamlining complex procedures and reducing equipment requirements. Complimentarily, SureSight Mobile is a compact, portable video laryngoscope with a built-in screen, designed for rapid, ready-to-use deployment across hospital wards and emergency settings.
In addition, SureSight also helps clinicians document intubation directly and transfer images and videos to electronic health records in hospitals. This integrated documentation capability is designed to further enhance workflow efficiency, allowing clinicians to maximize their focus on the patient.
Britt Meelby Jensen, CEO of Ambu, states, “Now that the entire SureSight portfolio is available across Europe, we are enhancing our Respiratory platform with an integrated video laryngoscopy solution. This offering supports clinicians in working both efficiently and confidently during challenging airway intubations. I am thrilled to introduce these comprehensive solutions within Europe, further solidifying our leadership in single-use endoscopy.”
|
About Ambu’s SureSight portfolio |
|
The SureSight portfolio is part of Ambu’s Respiratory platform, which includes single-use bronchoscopes, video laryngoscopes, camera-equipped endotracheal tubes, and endoscopy systems that provide clinicians in Europe with all the necessary airway visualization solutions. It supports advanced intubation techniques, such as video-assisted fiberoptic intubation, enabling clinicians to manage airways effectively while complying with established guidelines using a single system.
Ambu’s SureSight portfolio consists of:
|
----------------------------------------
1 Ruetzler K, Bustamante S, Schmidt MT, et al.: Video Laryngoscopy vs Direct Laryngoscopy for Endotracheal Intubation in the Operating Room: A Cluster Randomized Clinical Trial. JAMA. 2024;331(15):1279–1286. doi:10.1001/jama.2024.0762
2 Dr. Christodoulides has not been compensated for his quote in this press release.
Contacts
Anders HjortHead of Investor Relations
Tel:+45 2892 8881anhj@ambu.comTine Bjørn SchmidtDirector of Corporate Communications
Tel:+45 2264 0697tisc@ambu.comSubscribe to releases from Ambu A/S
Subscribe to all the latest releases from Ambu A/S by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Ambu A/S
INTRODUCING AMBU® SURESIGHT™ MOBILE VIDEO LARYNGOSCOPE2.12.2025 13:36:10 CET | Press release
Following the launch of Ambu® SureSight™ Connect in the U.S. and Great Britain in the first half of 2025, Ambu now expands its video laryngoscope portfolio with Ambu® SureSight™ Mobile – a video laryngoscope with an integrated screen for emergent and unplanned intubations across clinical settings.
AMBU EXPANDS RECYCLING PROGRAM TO INCLUDE VIDEO LARYNGOSCOPE BLADES29.10.2025 14:49:09 CET | Press release
Today, Ambu announces an extension of its Ambu® Recircle Program, now to include blades from the newly launched video laryngoscopy solution, Ambu® SureSight™ Connect.
FRIENDLY REMINDER: AMBU CAPITAL MARKETS DAY 202510.9.2025 12:48:28 CEST | Press release
This is a friendly reminder to secure your seat for in-person attendance at Ambu’s Capital Markets Day, taking place on 1 October 2025 from 10:00 to 16:30 CEST at our headquarters in Denmark, Baltorpbakken 13, 2750 Ballerup. We look forward to welcoming institutional investors, analysts, and financial media for a day of insights on strategy and market opportunities. Furthermore, it is an opportunity to meet with the broader Executive Leadership Team, as well as key external speakers. Finally, there will be a product demonstration at the end of the event, offering participants the opportunity to experience Ambu’s solutions firsthand. All presentations and Q&As are held from 10:00-15:00 CEST. The presentations will be held in English, and they will be recorded. After the event, the recorded presentations and the presentation materials will be published on Ambu’s website. The product demonstration will run from 15:00-16:30 CEST and will be for in-person attendees only. SIGN UP FOR IN-PERS
AMBU APPOINTS NEW PRESIDENT OF NORTH AMERICA REGION22.8.2025 07:10:00 CEST | Press release
Steven Block steps down; Scott Heinzelman appointed as new President to drive Ambu’s strong growth trajectory in North America.
AMBU CAPITAL MARKETS DAY 20257.8.2025 15:25:11 CEST | Press release
Ambu invites institutional investors, analysts, and financial media to the company’s Capital Markets Day on Wednesday 1 October 2025.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom